These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29679767)

  • 41. Unlocking the opportunity of tight glycaemic control. Far from goal.
    Del Prato S
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).
    Terauchi Y; Koyama M; Cheng X; Sumi M; Riddle MC; Bolli GB; Hirose T;
    Diabetes Metab; 2017 Oct; 43(5):446-452. PubMed ID: 28433560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of glycaemic variability on the surgical patient.
    Dhatariya K; Levy N; Hall GM
    Curr Opin Anaesthesiol; 2016 Jun; 29(3):430-7. PubMed ID: 26910050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of diabetes medications for patients undergoing ambulatory surgery.
    Vann MA
    Anesthesiol Clin; 2014 Jun; 32(2):329-39. PubMed ID: 24882121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.
    Ghosh S; Unnikrishnan AG; Saboo B; Kesavadev J; Aravind SR; Bajaj S; Rajput R; Seshadri K; Verma N; Gupta A; Makkar BM; Saikia M; Kale S; Damodaran S; Dengra A; Eashwar TKM; Maheshwari A; Pendsey S; Phatak SR; Sharma SK; Singh SK; Ramachandran A; Zargar AH; Joshi SR; Sadikot SM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S507-S521. PubMed ID: 28433618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin aspart: a review.
    Owens D; Vora J
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poor glycaemic control and retinopathy in non-insulin-dependent diabetes mellitus.
    Bastyr EJ; Janes J; Barnett AH
    Diabet Med; 1997 Nov; 14(11):993-4. PubMed ID: 9400930
    [No Abstract]   [Full Text] [Related]  

  • 50. Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.
    Simha V; Shah P
    JAMA; 2019 Jan; 321(4):399-400. PubMed ID: 30615031
    [No Abstract]   [Full Text] [Related]  

  • 51. [Misleading about type 2 diabetes and insulin].
    Meland E
    Tidsskr Nor Laegeforen; 2005 Dec; 125(24):3519-20; author reply 3520. PubMed ID: 16357910
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of diabetes mellitus: general goals, and clinical practice management].
    Simó R; Hernández C
    Rev Esp Cardiol; 2002 Aug; 55(8):845-60. PubMed ID: 12199981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perioperative management of ambulatory surgical patients with diabetes mellitus.
    Vann MA
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):718-24. PubMed ID: 19696663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.
    Welsh JB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S242-S249. PubMed ID: 29916736
    [No Abstract]   [Full Text] [Related]  

  • 55. [Good glycaemic control can prevent diabetic peripheral neuropathy].
    Gregersen S
    Ugeskr Laeger; 2013 Sep; 175(36):2022-5. PubMed ID: 23992909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cell therapy and gene therapy in diabetes mellitus].
    Seufert J
    MMW Fortschr Med; 2004 May; 146(20):39-40. PubMed ID: 15344732
    [No Abstract]   [Full Text] [Related]  

  • 58. Premixed insulin analogues for the treatment of diabetes mellitus.
    Garber AJ
    Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Technology in Diabetes Treatment: Update and Future.
    Schiel R; Bambauer R; Steveling A
    Artif Organs; 2018 Nov; 42(11):1017-1027. PubMed ID: 30334582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Misleading about insulin administration to patients with diabetes].
    Johansen OE; Birkeland KI
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2247; author reply 2247. PubMed ID: 16138161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.